Arginine-aspartate and haloperidol-induced neurobehavioral effects in the rat

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 29-32

  Patacchioli, Francesca Romana ^a   Di Grezia, Renato ^a   Angelucci, Luciano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Arginine aspartate; Catalepsy; Dopamine; Haloperidol; Locomotor activity

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ARGININE ASPARTATE; DOPAMINE; HALOPERIDOL; HOMOVANILLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0029943813     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00847-0     Document Type: Article

References (15)

1. Andén, N.E., 1972, Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugs, J. Pharm. Pharmacol. 24, 905.
2. Campistron, G., R. Guiraud, J. Cros and J. Mosser, 1982a, Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat. I. Plasma kinetics, Eur. J. Drug Metab. Pharmacokin. 7, 307.
3. Campistron, G., R. Guiraud, J. Cros and G. Prat, 1982b, Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat. II. Tissue distribution, Eur. J. Drug Metab. Pharmacokin. 7, 315.
4. Campistron, G., R. Guiraud, J. Cros and H. Pontagnier, 1983, Pharmacokinetics of arginine and aspartic acid administered simultaneously in the rat. III. Changes in the levels of amino acids in the plasma, liver and brain after simultaneous administration of arginine and aspartic acid, Eur. J. Drug Metab. Pharmacokin. 8, 281.
5. Cehovic, G., 1983, Role des petits peptides sur la phosphorylation des protéines cérébrales in vitro, Acad. Sci. Paris 296, 351.
6. Co, C., J.E. Smith and J.D. Lane, 1982, Use a single compartment LCEC cell in the determinations of biogenic amine content and turnover, Pharmacol. Biochem. Behav. 16, 641.
7. Ferré, S., T. Guiz, G. Prat, F. Jane and M. Casas, 1990, Is experimental catalepsy properly measured?, Pharmacol. Biochem. Behav. 35, 753.
8. Ghigo, E., G.P. Ceda, R. Valcavi, S. Goffi, M. Zini, M. Mucci, G. Valenti, D. Cocchi, E.E. Muller and F. Camanni, 1994, Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects, J. Endocrinol. Invest. 1994.
9. Honma, T. and H. Fukushima, 1976, Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics, Neuropharmacology 15, 601.
10. Lowry, O.H., N.J. Rosebrough, A. Farr and R.J. Randall, 1951, Protein measurements with the Polin phenol reagent, J. Biol. Chem. 193, 265.
11. O'Keeffe, R., D.F. Sharman and M. Vogt, 1970, Effect of drugs used in psychoses on cerebral dopamine metabolism, Br. J. Pharmacol. 38, 287.
12. Paillot M., J. Mouradoff and J.-P. Cagnet, 1961, Traitement de l'asthénie physique et psychique due aux neuroleptiques, Psychol. Méd. 3, 2.
13. Patacchioli, F.R., M.A. Di Cesare, M.A. Micci and L. Angelucci, 1990, Effect of on free amino acid levels in various brain regions and pituitary of stressed rats, in: Amino Acids, Chemistry, Biology and Medicine, eds. G. Lubec and G.A. Rosenthal (Escom, Leiden) p. 607.
14. Sanberg, P.R., M. Giordano, M.D. Bunsey and A.B. Norman, 1988, The catalepsy test: its ups and downs, Behav. Neurosci. 102, 748.
15. Winer, B.J., 1962, Statistical Principles in Experimental Design (McGraw Hill Kogakusha, Tokio).